title: Clinical evolution of neuroretinitis in Parry-Romberg syndrome.
abstract: A 16-year-old girl with Parry-Romberg syndrome presented with monolateral exudative neuroretinitis and retinal telangiectasis that had been observed for 42 months. She was treated with immunosuppressive therapy with A-cyclosporine for 1 year, followed by laser treatment of telangiectasis. Her visual acuity improved from 20/200 to 20/70 in 1 year with a reduction of neuroretinal exudation. Laser treatment resulted in a further improvement of visual acuity to 20/40. Clinical findings remained unchanged during 2 years of follow-up. The association of immunosuppressive treatment and laser therapy may improve neuroretinal disease in the presence of Parry-Romberg syndrome.
authors.affiliation: Department of Ophthalmology, University Federico II, Via Pansini 5, 80131, Naples, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: de Crecchio
authors.forename: Raimondo
authors.initials: R
authors.lastname: Forte
authors.forename: Diego
authors.initials: D
authors.lastname: Strianese
authors.forename: Michele
authors.initials: M
authors.lastname: Rinaldi
authors.forename: Antonella
authors.initials: A
authors.lastname: D'Aponte
mesh_terms: D000293:Adolescent; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000627:therapeutic use; D005150:Facial Hemiatrophy / Q000150:complications*; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017075:Laser Coagulation; D012173:Retinitis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D013684:Telangiectasis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine